Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06841796 · ClinicalTrials.gov registry record · NA
The YMCA Healthy Lifestyle Program for Prediabetes
A NA study of PreDiabetes, sponsored by Young Men's Christian Association of the Blue Water Area.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06841796: Recruiting NA study of PreDiabetes, sponsored by Young Men's Christian Association of the Blue Water Area.
NCT06841796 is a NA study of PreDiabetes that is actively recruiting participants, run by Young Men's Christian Association of the Blue Water Area. The registered enrollment target is 84 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06841796, a NA study of PreDiabetes, is actively recruiting participants, sponsored by Young Men's Christian Association of the Blue Water Area.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this 26 week randomized controlled clinical trial is to learn if using a real time continuous glucose monitor (CGM) in a healthy lifestyle program for adults with prediabetes at the YMCA can improve glucose levels, dietary habits and physical activity The main questions it aims to answer is * Does use of a CGM improve the percent of time spent with glucose values between 70-140 mg/dl * Does use of a CGM improve nutritional habits as measured by Picture Your Plate (PYP) score * Does use of a CGM improve physical activity as measured by International Physical Activity Questionnaire (IPAQ) score Researchers will compare individuals using real time CGM to those not using CGM Participants will be asked to: * attend weekly health coach sessions for 12 weeks followed by 3 monthly sessions. * attend a YMCA class of their choice * fill out questionnaires at baseline, 12 and 24 weeks * have an A1c blood test at baseline, 12 and 24 weeks. * wear a CGM. All participants will wear a blinded CGM at baseline. The intervention group will wear a real time CGM for 24 weeks. The control group will wear a blinded CGM for 10 days at 6, 12 and 24 weeks
Primary Outcome
Percent of time with glucose values in the range of 70-140 mg/dl
Conditions Studied
Interventions
- DEVICE Real time continuous glucose monitor (Stelo)
Study Locations (1)
Michigan
- YMCA of the Blue Water Area - Port Huron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06841796 shows while recruiting
NCT06841796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (88% lower).
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Real time continuous glucose monitor (Stelo) is the first listed.
NCT06841796 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06841796 about?
NCT06841796 is a clinical study titled "The YMCA Healthy Lifestyle Program for Prediabetes". The goal of this 26 week randomized controlled clinical trial is to learn if using a real time continuous glucose monitor (CGM) in a healthy lifestyle program for adults with prediabetes at the YMCA can improve glucose levels, dietary habits and physical activity The main questions it aims to answer...
What is the current status of trial NCT06841796?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2025-02-17. Estimated completion is 2026-10.
What conditions does trial NCT06841796 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT06841796?
The interventions under investigation include: Real time continuous glucose monitor (Stelo) (DEVICE).
Who is sponsoring clinical trial NCT06841796?
This trial is sponsored by Young Men's Christian Association of the Blue Water Area, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06841796 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06841796's enrollment target sits among peer trials
84 69th of 149 higher than 81 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI